TNFSF10 and malignant colon neoplasm: The findings of in vitro and in vivo anticancer studies using human colon cancer HCT116 cells confirmed that TRAIL-Cur-NPs showed an enhanced antitumor ability because of high tumor targeting and synergistic effect of TRAIL and Cur.